A Phase 1 Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients with Refractory or Recurrent Neuroblastoma or Medulloblastoma (Q46188537)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase 1 Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients with Refractory or Recurrent Neuroblastoma or Medulloblastoma |
scientific article |
Statements
1 reference
A Phase 1 Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients with Refractory or Recurrent Neuroblastoma or Medulloblastoma (English)
1 reference
Deanna Mitchell
1 reference
Genevieve Bergendahl
1 reference
William Ferguson
1 reference
William Roberts
1 reference
Timothy Higgins
1 reference
Takamaru Ashikaga
1 reference
Mike DeSarno
1 reference
Joel Kaplan
1 reference
Jacqueline Kraveka
1 reference
Don Eslin
1 reference
Alyssa Vander Werff
1 reference
Gina K Hanna
1 reference
Giselle L Saulnier Sholler
1 reference
31 July 2015
1 reference
63
1 reference
1
1 reference
39-46
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference